These results support the idea that TME-derived signals induce monocytic precursor cells to undergo in situ proliferation to increase cell numbers, and subpopulations of the proliferating cells subsequently differentiate into the CD163+ TAMs that poorly support anti-tumour T cell activities in situ. This evidence concerns the gene CD163 and neoplasm.